The Claim
Among Emirati adults with cardiovascular risk factors, long-term statin therapy (10 years) is associated with a 5.2% incidence of new-onset diabetes, representing a small absolute risk that must be balanced against the cardiovascular benefits of statin use.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In Emirati adults with heart disease risk factors, taking statins for 10 years leads to new-onset diabetes in about 5 out of every 100 people. This risk is small compared to the protection statins provide against heart attacks and strokes.
See the scientific wording
Among Emirati adults with cardiovascular risk factors, one in 19.2 individuals treated with statins for 10 years will develop new-onset diabetes, indicating a small but clinically relevant absolute risk that must be weighed against the substantial cardiovascular benefits of statin therapy.
Statins reduce the production of a molecule that helps cells take up sugar and also make it harder for the pancreas to release enough insulin, causing blood sugar to rise over time until diabetes develops.
What the research says
1 studyFor every 19 Emiratis with heart risks who take statins for 10 years, about one might get diabetes — but many more heart attacks and strokes are prevented, so the benefits still outweigh the risk.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.